US 10076520
Use of tyrosine kinase inhibitor in cancer treatment
granted A61KA61K31/496A61K31/5025
Quick answer
US patent 10076520 (Use of tyrosine kinase inhibitor in cancer treatment) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/496, A61K31/5025, A61K31/506, A61K31/517